BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20014883)

  • 1. High-intensity focused ultrasound: where are we and where to from here?
    Williams AK; Martínez CH; Chalasani V; Chin J
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):33-40. PubMed ID: 20014883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High intensity focused ultrasound (HIFU).
    Barkin J
    Can J Urol; 2011 Apr; 18(2):5634-43. PubMed ID: 21504653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-intensity focused ultrasound for localized prostate cancer].
    Uchida T
    Nihon Rinsho; 2005 Feb; 63(2):345-9. PubMed ID: 15714990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
    Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
    Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and results of high-intensity focused ultrasound for localized prostate cancer.
    Colombel M; Gelet A
    Prostate Cancer Prostatic Dis; 2004; 7(4):289-94. PubMed ID: 15452554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role.
    Chaussy CG; Thüroff S
    Arch Esp Urol; 2011 Jul; 64(6):493-506. PubMed ID: 21791716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy.
    Uchida T; Shoji S; Nakano M; Hongo S; Nitta M; Usui Y; Nagata Y
    BJU Int; 2011 Feb; 107(3):378-82. PubMed ID: 21265984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound].
    Poissonnier L; Murat FJ; Belot A; Bouvier R; Rabilloud M; Rouviere O; Chapelon JY; Gelet A
    Prog Urol; 2008 Apr; 18(4):223-9. PubMed ID: 18501302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
    Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
    Urologiia; 2007; (6):39-44. PubMed ID: 18649659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of localized prostate cancer using high-intensity focused ultrasound.
    Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
    BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Dudderidge T; Ahmed H; Emberton M
    BJU Int; 2009 Oct; 104(8):1170-1; author reply 1171. PubMed ID: 19764975
    [No Abstract]   [Full Text] [Related]  

  • 19. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
    Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
    Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIFU and cryoablation--non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound?
    Wondergem N; De La Rosette JJ
    Minim Invasive Ther Allied Technol; 2007; 16(1):22-30. PubMed ID: 17365674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.